Changes in Beneficial Ownership · 4
Century Therapeutics, Inc.
IPSCNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4-09102026_090949.xml
Filing details
- Report period
- 2026-09-09
- Issuer
- Century Therapeutics, Inc.
- Issuer CIK
- 0001850119
- Trading symbol
- IPSC
Reporting owner 1
- Name
- Truitt Joseph
- Reporting owner CIK
- 0001452429
- Relationship
- Director
- Address
- C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA, 19104
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | 2.03 | 2026-09-09 | A · Form 4 | 148,000 | A | 0 | [F1] | 2036-09-09 | Common Stock | 148,000 | 148,000 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.↩ 1
Signature 1
- Signed
- /s/ Douglas Carr, Attorney-in-Fact
- Date
- 2026-09-10
Company context
Century Therapeutics (NASDAQ: IPSC) is a biotechnology company advancing a pipeline of iPSC-derived cell therapies with the potential to meaningfully address autoimmune diseases, including T1D, and cancer. Century's therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. For more information on Century Therapeutics, please visit www.centurytx.com and connect with us on LinkedIn.